XML 30 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
ATM Program [Member]
Common Stock [Member]
ATM Program [Member]
Additional Paid-in Capital [Member]
ATM Program [Member]
Retained Earnings [Member]
ATM Program [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2018         17,089,000      
Balance at Dec. 31, 2018         $ 171 $ 119,764 $ (114,981) $ 4,954
Net loss         (4,189) (4,189)
Vesting of restricted stock awards (in shares)         6,000      
Vesting of restricted stock awards         10 10
Stock-based compensation expense related to employee and director stock options         107 107
Stock-based compensation expense related to non-employee stock options         7 7
Reclassification of Warrant Liability to Equity – see Note 2         412 (356) 56
Debt discount associated with convertible note – beneficial conversion feature         184 184
Balance (in shares) at Mar. 31, 2019         17,095,000      
Balance at Mar. 31, 2019         $ 171 120,484 (119,526) 1,129
Balance (in shares) at Dec. 31, 2018         17,089,000      
Balance at Dec. 31, 2018         $ 171 119,764 (114,981) 4,954
Net loss               $ (6,690)
Balance (in shares) at Jun. 30, 2019         20,733,000      
Issuance of common stock for option exercises (in shares)               83,000
Balance at Jun. 30, 2019         $ 207 123,518 (122,056) $ 1,669
Balance (in shares) at Mar. 31, 2019         17,095,000      
Balance at Mar. 31, 2019         $ 171 120,484 (119,526) 1,129
Net loss         (2,501) (2,501)
Issuance of common stock in connection with exercise of warrants (in shares)         286,000      
Issuance of common stock in connection with exercise of warrants         $ 3 443 446
Stock-based compensation expense related to employee and director stock options         7 7
Stock-based compensation expense related to non-employee stock options         95 95
Issuance of common stock, net of offering costs (in shares)         3,269,000      
Issuance of common stock, net of offering costs         $ 33 2,434 2,467
Stock option modification         21 21
Balance (in shares) at Jun. 30, 2019         20,733,000      
Down round feature adjustment related to warrants         29 (29)
Issuance of common stock for option exercises (in shares)         83,000     83,000
Issuance of common stock for option exercises         189 $ 189
Debt discount associated with convertible note – beneficial conversion feature         (184) (184)
Balance at Jun. 30, 2019         $ 207 123,518 (122,056) 1,669
Balance (in shares) at Dec. 31, 2019         27,938,000      
Balance at Dec. 31, 2019         $ 279 125,718 (125,024) 973
Net loss         (1,582) (1,582)
Issuance of common stock in connection with exercise of warrants (in shares)         299,000      
Issuance of common stock in connection with exercise of warrants         $ 3 198 201
Vesting of restricted stock awards (in shares)         2,000      
Vesting of restricted stock awards         2 2
Stock-based compensation expense related to employee and director stock options         45 45
Stock-based compensation expense related to non-employee stock options         12 12
Balance (in shares) at Mar. 31, 2020         28,239,000      
Balance at Mar. 31, 2020         $ 282 125,975 (126,606) (349)
Balance (in shares) at Dec. 31, 2019         27,938,000      
Balance at Dec. 31, 2019         $ 279 125,718 (125,024) 973
Net loss               (6,064)
Balance (in shares) at Jun. 30, 2020         34,648,000      
Balance at Jun. 30, 2020         $ 346 131,725 (131,088) 983
Balance (in shares) at Mar. 31, 2020         28,239,000      
Balance at Mar. 31, 2020         $ 282 125,975 (126,606) (349)
Net loss         (4,482) (4,482)
Issuance of common stock in connection with exercise of warrants (in shares)         571,000      
Issuance of common stock in connection with exercise of warrants         $ 6 462 468
Stock-based compensation expense related to employee and director stock options         92 92
Stock-based compensation expense related to non-employee stock options         (2) (2)
Issuance of common stock, net of offering costs (in shares) 5,838,000     5,836,792        
Issuance of common stock, net of offering costs $ 58 $ 5,162 $ 5,220        
Stock option modification         36 36
Balance (in shares) at Jun. 30, 2020         34,648,000      
Balance at Jun. 30, 2020         $ 346 $ 131,725 $ (131,088) $ 983